What CytoCrim was found guilty this week? (CYDY)

Yesterday, after a long trial, NaDDiR*, the former CEO of everybody’s favorite pink sheet reverse-merger Corona-n-Cancer-n-AIDS-crapper, Cytodyn (CYDY), and star of USA v. Pourhassan et al, in the U.S. District Court, District of Maryland, Case #: 8:22-cr-00440-PX, was found guilty on counts 2, 3, 4, 5, 7,10, 11, 12, and 13 of the Superseding Indictment (catch up on the indictment here).

The particulars of the verdict have been sealed by the court, so it might be a while until we get all the details. He did get off on the Conspiracy count (Count 1) and one of the Wire Fraud counts (Count 6).

Still no word on a sentencing date. Stay tuned.

What further Cytoklowning can we expect from the remnants of the klown krew as the Cytoscam stock promotion continues to lurch from one pivot to another?

* Spelled Thusly For A Double Dose of That Sweet Sweet Stock Pimping

THE CONTENT CONTAINED IN THIS BLOG REPRESENTS ONLY THE OPINIONS OF THE AUTHOR. THE AUTHOR MAY HOLD EITHER LONG OR SHORT POSITIONS IN SECURITIES OF VARIOUS COMPANIES DISCUSSED IN THE BLOG. THIS COMMENTARY IN NO WAY CONSTITUTES INVESTMENT ADVICE, AND SHOULD NEVER BE RELIED ON IN MAKING AN INVESTMENT DECISION, EVER. THIS BLOG IS NOT A SOLICITATION OF BUSINESS: ALL INQUIRIES WILL BE IGNORED. THE CONTENT HEREIN IS INTENDED SOLELY FOR THE ENTERTAINMENT OF THE READER, AND THE AUTHOR.

2 comments

Leave a Reply to BuyersStrike!Cancel reply